# Donepezil to Treat Dementia in Parkinson's Disease

> **NCT00030979** · PHASE4 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 28 (—)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT00030979
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 28 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030979, "Donepezil to Treat Dementia in Parkinson's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00030979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*